1
Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
2
Chronic Respiratory Disease Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract
Despite the fact that about two years have passed since the onset of the COVID-19 pandemic, there is still no curative treatment for the disease. Most cases of COVID-19 have mild or moderate illness and do not require hospitalization.
This guideline released by the National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Masih Daneshvari Hospital COVID-19 Expert Group to provide a treatment guide for outpatient management of COVID-19.
Rezaei,M. , Jamaati,H. , Tabarsi,P. , Moniri,A. , Marjani,M. and Velayati,A. A. (2021). NRITLD Protocol for the Management of Outpatient Cases of COVID-19. TANAFFOS (Respiration), 20(3), 192-196.
MLA
Rezaei,M. , , Jamaati,H. , , Tabarsi,P. , , Moniri,A. , , Marjani,M. , and Velayati,A. A. . "NRITLD Protocol for the Management of Outpatient Cases of COVID-19", TANAFFOS (Respiration), 20, 3, 2021, 192-196.
HARVARD
Rezaei M., Jamaati H., Tabarsi P., Moniri A., Marjani M., Velayati A. A. (2021). 'NRITLD Protocol for the Management of Outpatient Cases of COVID-19', TANAFFOS (Respiration), 20(3), pp. 192-196.
CHICAGO
M. Rezaei, H. Jamaati, P. Tabarsi, A. Moniri, M. Marjani and A. A. Velayati, "NRITLD Protocol for the Management of Outpatient Cases of COVID-19," TANAFFOS (Respiration), 20 3 (2021): 192-196,
VANCOUVER
Rezaei M., Jamaati H., Tabarsi P., Moniri A., Marjani M., Velayati A. A. NRITLD Protocol for the Management of Outpatient Cases of COVID-19. TANAFFOS (Respiration), 2021; 20(3): 192-196.
